País: Australia
Idioma: inglés
Fuente: Department of Health (Therapeutic Goods Administration)
The Binding Site Pty Limited
Class 2
The Binding Site Group Ltd 8 Calthorpe Road, Edgbaston, Birmingham, B15 1QT United Kingdom
CT353 - Bacterial infectious disease IVDs
Designed for the quantitative in vitro measurement of human anti-Streptolysin-O (ASO) in serum as an aid in the diagnosis of diseases caused by streptococcus bacterial infections including rheumatic fever, scarlet fever, glomerulonephritis, tonsillitis, upper respiratory tract infections and pyoderma.
A
2013-01-17